Synopsis of recent research by authors named "Eva K Hejboel"
Recent research by Eva K Hejboel focuses on the application of botulinum toxin type A (BTX-A) in the treatment of long-gap esophageal atresia (LGEA), specifically investigating its safety and effectiveness in enhancing esophageal elongation in animal models.
The studies reveal that endoscopic injections of BTX-A are feasible and safe, although they did not produce significant structural changes in the esophagus within three days post-injection.
Hejboel's findings emphasize the importance of optimizing dosing and timing in BTX-A applications to achieve maximal therapeutic effects for esophageal elongation, contributing valuable insights into minimally invasive surgical approaches for treating LGEA.
